With only weeks left in his presidency, Trump makes a final, long-shot bid to remake US drug pricing
As the curtain closes on his administration, President Donald Trump is using his final weeks in office to push one of his longest-running campaign promises of lowering prescription drug prices.
Trump announced in a brief Friday news conference that he would be instituting the “most favored nations” rule tying prices in the US to those in other developed countries, as well as ending certain rebates paid to middlemen, also known as pharmacy benefit managers, in Medicare. The two rules were part of a series of four executive orders Trump unveiled in July aimed at tackling high prescription costs.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.